Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIP: Vinorelbine in C5 High Grade Serous Ovarian Cancer
NCT03188159Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- Jul 2017
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of vinorelbine in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by National University Hospital. Status: unknown.
02
Drugs
vinorelbine
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT03188159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03188159.